Back

Genetic basis and molecular mechanisms in dilated cardiomyopathy (DCM)

13 April 2024 (08:45 - 09:00)
Organised by: Logo
Congress Presentation Part of: Hypertrophic and dilated cardiomyopathy: from molecular targets to therapy Cardiomyopathies CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Professor Jolanda van der Velden

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Cellular targets for drug therapy in HCM
Doctor R. Coppini (Florence, IT)
Slides
Presentation thumbnail
Gene therapy in laminopathies and DCM
Doctor A. Tijsen (Amsterdam, NL)
Slides
Presentation thumbnail
Meteorin-like regulates cardiac hypertrophy and associated metabolic plasticity during gestation and lactation
Mr A. Blasco-Roset (Barcelona, ES)
Abstract Slides

Access the full session

Session thumbnail
Hypertrophic and dilated cardiomyopathy: from molecular targets to therapy

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

13 April 2024 08:45 CET
You may be interested in
thumbnail
Congress Presentation
Clinical profile of the index case with idiopathic dilated cardiomyopathy requested genetic study.
29 June 2021
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments
17 May 2025
thumbnail
Congress Presentation
Leveraging the shared and opposing genetic mechanisms in the heritable cardiomyopathies for gene discovery
1 September 2025
thumbnail
Webinar
New concepts in dilated and non-dilated LV cardiomyopathies. ESC 2023 Clinical Practice Guidelines - Webinar Series
18 October 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources